●
formation of hematomas/seromas or cysts
●
heart block
●
heart wall or vein wall rupture
●
hemothorax
●
infection
●
keloid formation
●
lead abrasion and discontinuity
●
lead migration/dislodgement
●
mortality due to inability to deliver therapy
●
muscle and/or nerve stimulation
●
myocardial damage
●
myocardial irritability
●
myopotential sensing
●
pericardial effusion
●
pericardial rub
●
pneumothorax
●
poor connection of the lead to the device, which may lead to oversensing, undersensing,
or a loss of therapy
●
threshold elevation
●
thrombotic embolism
●
thrombosis
●
tissue necrosis
●
valve damage (particularly in fragile hearts)
●
venous occlusion
●
venous perforation
Additional potential adverse events associated with the use of ICD systems include, but are
not limited to, the following events:
●
inappropriate shocks
●
potential mortality due to inability to defibrillate
●
shunting current or insulating myocardium during defibrillation
Medtronic
PROTECTA™ XT DR D314DRG
Clinician Manual
39
Содержание PROTECTA XT DR D314DRG
Страница 2: ......
Страница 9: ...Index 488 Medtronic PROTECTA XT DR D314DRG Clinician Manual 9 ...
Страница 506: ......
Страница 507: ......